|
1
|
Iglesia CB and Smithling KR: Pelvic Organ
Prolapse. Am Fam Physician. 96:179–185. 2017.PubMed/NCBI
|
|
2
|
Weintraub AY, Glinter H and Marcus-Braun
N: Narrative review of the epidemiology, diagnosis and
pathophysiology of pelvic organ prolapse. Int Braz J Urol. 46:5–14.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Collins S and Lewicky-Gaupp C: Pelvic
Organ Prolapse. Gastroenterol Clin North Am. 51:177–193.
2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Selihova MS, Ershov GV and Ershov AG:
Pelvic organ prolapse, a hidden epidemic of the 21st century. Adv
Gerontol. 34:431–437. 2021.PubMed/NCBI(In Russian).
|
|
5
|
Resende APM, Bernardes BT, Stüpp L,
Oliveira E, Castro RA, Girão MJBC and Sartori MGF: Pelvic floor
muscle training is better than hypopressive exercises in pelvic
organ prolapse treatment: An assessor-blinded randomized controlled
trial. Neurourol Urodyn. 38:171–179. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Roos AM, Thakar R, Sultan AH, de Leeuw JW
and Paulus AT: The impact of pelvic floor surgery on female sexual
function: A mixed quantitative and qualitative study. BJOG.
121:92–100; discussion 101. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kalata U, Jarkiewicz MM and Barcz EM:
Depression and anxiety in patients with pelvic floor disorders.
Ginekol Pol. 94:748–751. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Walker GJ and Gunasekera P: Pelvic organ
prolapse and incontinence in developing countries: review of
prevalence and risk factors. Int Urogynecol J. 22:127–135.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Al-Badr A, Saleem Z, Kaddour O, Almosaieed
B, Dawood A, Al-Tannir M, AlTurki F, Alharbi R and Alsanea N:
Prevalence of pelvic floor dysfunction: A Saudi national survey.
BMC Womens Health. 22(27)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Eickmeyer SM: Anatomy and Physiology of
the Pelvic Floor. Phys Med Rehabil Clin N Am. 28:455–460.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
McLeod LJ and Lee PE: Pelvic organ
prolapse. CMAJ. 195(E1013)2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pelvic Organ Prolapse. Female Pelvic Med
Reconstr Surg. 23:353–364. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cecati M, Corradetti A, Sartini D, Pozzi
V, Giannubilo SR, Saccucci F, Ciavattini A and Emanuelli M:
Expression of extracellular matrix and adhesion proteins in pelvic
organ prolapse. Cell Mol Biol (Noisy-le-grand). 64:142–148.
2018.PubMed/NCBI
|
|
14
|
Tian Z, Li Q, Wang X and Sun Z: The
difference in extracellular matrix metabolism in women with and
without pelvic organ prolapse: A systematic review and
meta-analysis. BJOG. 131:1029–1041. 2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ying W, Hu Y and Zhu H: Expression of
CD44, Transforming Growth Factor-β, and matrix metalloproteinases
in women with pelvic organ prolapse. Front Surg.
9(902871)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Haylen BT, Maher CF, Barber MD, Camargo S,
Dandolu V, Digesu A, Goldman HB, Huser M, Milani AL, Moran PA, et
al: An International Urogynecological Association
(IUGA)/International Continence Society (ICS) Joint Report on the
Terminology for Female Pelvic Organ Prolapse (POP). Neurourol
Urodyn. 35:137–168. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhu L, Li L, Lang J, Xu T and Wong F:
Epidemiology of mixed urinary incontinence in China. Int J Gynaecol
Obstet. 109:55–58. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kato J, Nagata C, Miwa K, Ito N and
Morishige KI: Pelvic organ prolapse and Japanese lifestyle:
Prevalence and risk factors in Japan. Int Urogynecol J. 33:47–51.
2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li Z, Xu T, Li Z, Gong J, Liu Q and Zhu L:
An epidemiologic study of pelvic organ prolapse in rural Chinese
women: A population-based sample in China. Int Urogynecol J.
30:1925–1932. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nygaard IE and Shaw JM: Physical activity
and the pelvic floor. Am J Obstet Gynecol. 214:164–171.
2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cattani L, Decoene J, Page AS, Weeg N,
Deprest J and Dietz HP: Pregnancy, labour and delivery as risk
factors for pelvic organ prolapse: A systematic review. Int
Urogynecol J. 32:1623–1631. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rogowski A, Bienkowski P, Tarwacki D,
Dziech E, Samochowiec J, Jerzak M and Baranowski W: Association
between metabolic syndrome and pelvic organ prolapse severity. Int
Urogynecol J. 26:563–568. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gava G, Alvisi S, Mancini I, Seracchioli R
and Meriggiola MC: Prevalence of metabolic syndrome and its
components in women with and without pelvic organ prolapse and its
association with prolapse severity according to the Pelvic Organ
Prolapse Quantification system. Int Urogynecol J. 30:1911–1917.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
American College of Obstetricians and
Gynecologists and the American Urogynecologic Society; INTERIM
UPDATE. This Practice Bulletin is updated as highlighted to reflect
the US Food and Drug Administration order to stop the sale of
transvaginal synthetic mesh products for the repair of pelvic organ
prolapse: Pelvic Organ Prolapse. Female Pelvic Med Reconstr Surg.
25:397–408. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu H, Wu W, Xiang W and Yuan J: Lifestyle
factors, metabolic factors and socioeconomic status for pelvic
organ prolapse: A Mendelian randomization study. Eur J Med Res.
28(183)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Rostaminia G, Peck JD, Quiroz LH and
Shobeiri SA: Characteristics associated with pelvic organ prolapse
in women with significant levator ani muscle deficiency. Int
Urogynecol J. 27:261–267. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Patel DA, Xu X, Thomason AD, Ransom SB,
Ivy JS and DeLancey JO: Childbirth and pelvic floor dysfunction: An
epidemiologic approach to the assessment of prevention
opportunities at delivery. Am J Obstet Gynecol. 195:23–28.
2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wu JM, Vaughan CP, Goode PS, Redden DT,
Burgio KL, Richter HE and Markland AD: Prevalence and trends of
symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol.
123:141–148. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lipschuetz M, Cohen SM,
Liebergall-Wischnitzer M, Zbedat K, Hochner-Celnikier D, Lavy Y and
Yagel S: Degree of bother from pelvic floor dysfunction in women
one year after first delivery. Eur J Obstet Gynecol Reprod Biol.
191:90–94. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Samimi P, Jones SH and Giri A: Family
history and pelvic organ prolapse: a systematic review and
meta-analysis. Int Urogynecol J. 32:759–774. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cheng C, Guo B, Li R, Wu W, Mi C and Li X:
Correlation between postpartum pelvic floor dysfunction and vaginal
microecological imbalance in late pregnancy. Zhong Nan Da Xue Xue
Bao Yi Xue Ban. 47:1608–1614. 2022.PubMed/NCBI View Article : Google Scholar : (In English,
Chinese).
|
|
32
|
Altman D, Falconer C, Cnattingius S and
Granath F: Pelvic organ prolapse surgery following hysterectomy on
benign indications. Am J Obstet Gynecol. 198:572.e1–e6.
2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Farrell SA, Baskett TF and Farrell KD: The
choice of elective cesarean delivery in obstetrics: A voluntary
survey of Canadian health care professionals. Int Urogynecol J
Pelvic Floor Dysfunct. 16:378–383. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhao Y, Zou L, Xiao M, Tang W, Niu HY and
Qiao FY: Effect of different delivery modes on the short-term
strength of the pelvic floor muscle in Chinese primipara. BMC
Pregnancy Childbirth. 18(275)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mant J, Painter R and Vessey M:
Epidemiology of genital prolapse: observations from the Oxford
Family Planning Association Study. Br J Obstet Gynaecol.
104:579–585. 1997.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kearney R, Miller JM, Ashton-Miller JA and
DeLancey JO: Obstetric factors associated with levator ani muscle
injury after vaginal birth. Obstet Gynecol. 107:144–149.
2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Blomquist JL, Carroll M, Muñoz A and Handa
VL: Pelvic floor muscle strength and the incidence of pelvic floor
disorders after vaginal and cesarean delivery. Am J Obstet Gynecol.
222:62.e1–62.e8. 2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kayembe AT, Kayembe CDKK, Bebele JK and
Tozin RR: Factors associated with genital prolapse to Saint Joseph
Hospital of Kinshasa. Pan Afr Med J. 40(234)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Reimers C, Siafarikas F, Stær-Jensen J,
Småstuen MC, Bø K and Ellström Engh M: Risk factors for anatomic
pelvic organ prolapse at 6 weeks postpartum: a prospective
observational study. Int Urogynecol J. 30:477–482. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Leijonhufvud A, Lundholm C, Cnattingius S,
Granath F, Andolf E and Altman D: Risks of stress urinary
incontinence and pelvic organ prolapse surgery in relation to mode
of childbirth. Am J Obstet Gynecol. 204:70.e1–e7. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Handa VL, Blomquist JL, McDermott KC,
Friedman S and Muñoz A: Pelvic floor disorders after vaginal birth:
effect of episiotomy, perineal laceration, and operative birth.
Obstet Gynecol. 119 (2 Pt 1):233–239. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Fuermetz A, Schoenfeld M, Ennemoser S,
Muetzel E, Jeschke U and Jundt K: Change of steroid receptor
expression in the posterior vaginal wall after local estrogen
therapy. Eur J Obstet Gynecol Reprod Biol. 187:45–50.
2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Rahn DD, Richter HE, Sung VW, Hynan LS and
Pruszynski JE: Effects of preoperative intravaginal estrogen on
pelvic floor disorder symptoms in postmenopausal women with pelvic
organ prolapse. Am J Obstet Gynecol. 229:309.e1–309.e10.
2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lara LA, Ribeiro da Silva A, Rosa-e-Silva
JC, Silva-de-Sá MF and Rosa-e-Silva AC: Estrogen receptor
expression and vessel density in the vagina wall in postmenopausal
women with prolapse. Tissue Cell. 46:159–164. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Vergeldt TF, Weemhoff M, IntHout J and
Kluivers KB: Risk factors for pelvic organ prolapse and its
recurrence: A systematic review. Int Urogynecol J. 26:1559–1573.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ewies AA, Thompson J and Al-Azzawi F:
Changes in gonadal steroid receptors in the cardinal ligaments of
prolapsed uteri: immunohistomorphometric data. Hum Reprod.
19:1622–1628. 2004.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zbucka-Kretowska M, Marcus-Braun N, Eboue
C, Abeguile G, Wolczynski S, Kottler ML and Von Theobald P:
Expression of estrogen receptors in the pelvic floor of pre- and
post-menopausal women presenting pelvic organ prolapse. Folia
Histochem Cytobiol. 49:521–527. 2011.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ramalingam K and Monga A: Obesity and
pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol.
29:541–547. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
de Sam Lazaro S, Nardos R and Caughey AB:
Obesity and pelvic floor dysfunction: Battling the Bulge. Obstet
Gynecol Surv. 71:114–125. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Swift S, Woodman P, O'Boyle A, Kahn M,
Valley M, Bland D, Wang W and Schaffer J: Pelvic Organ Support
Study (POSST): The distribution, clinical definition, and
epidemiologic condition of pelvic organ support defects. Am J
Obstet Gynecol. 192:795–806. 2005.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liu X, Rong Q, Liu Y, Wang J, Xie B and
Ren S: Relationship between high intra-abdominal pressure and
compliance of the pelvic floor support system in women without
pelvic organ prolapse: A finite element analysis. Front Med
(Lausanne). 9(820016)2022.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Reddy J, Barber MD, Walters MD, Paraiso MF
and Jelovsek JE: Lower abdominal and pelvic pain with advanced
pelvic organ prolapse: A case-control study. Am J Obstet Gynecol.
204:537.e1–e5. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Tan YH, Gillor M and Dietz HP: Abdominal
pressure and pelvic organ prolapse: Is there an association? Int
Urogynecol J. 33:337–342. 2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Matsuyama A, Kato K, Suzuki S, Nishiko Y,
Sai H, Ishiyama A, Kato T, Inoue S, Hirabayashi H and Hattori R:
Pelvic organ prolapse and inguinal hernia aggravated by ovarian
fibrothecoma with ascites. Nihon Hinyokika Gakkai Zasshi.
112:137–140. 2021.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
55
|
Spahlinger DM, Newcomb L, Ashton-Miller
JA, DeLancey JO and Chen L: Relationship between intra-abdominal
pressure and vaginal wall movements during Valsalva in women with
and without pelvic organ prolapse: Technique development and early
observations. Int Urogynecol J. 25:873–881. 2014.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Chen CCG, Avondstondt AM, Khatry SK, Singh
M, Klasen EM, LeClerq SC, Katz J, Tielsch JM and Mullany LC:
Prevalence of symptomatic urinary incontinence and pelvic organ
prolapse among women in rural Nepal. Int Urogynecol J.
31:1851–1858. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Hokenstad ED, Glasgow AE, Habermann EB and
Occhino JA: Readmission and Reoperation After Surgery for Pelvic
Organ Prolapse. Female Pelvic Med Reconstr Surg. 23:131–135.
2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Buchsbaum GM, Duecy EE, Kerr LA, Huang LS,
Perevich M and Guzick DS: Pelvic organ prolapse in nulliparous
women and their parous sisters. Obstet Gynecol. 108:1388–1393.
2006.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Jack GS, Nikolova G, Vilain E, Raz S and
Rodríguez LV: Familial transmission of genitovaginal prolapse. Int
Urogynecol J Pelvic Floor Dysfunct. 17:498–501. 2006.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Altman D, Forsman M, Falconer C and
Lichtenstein P: Genetic influence on stress urinary incontinence
and pelvic organ prolapse. Eur Urol. 54:918–922. 2008.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Allen-Brady K, Cannon-Albright L, Farnham
JM, Teerlink C, Vierhout ME, van Kempen LCL, Kluivers KB and Norton
PA: Identification of six loci associated with pelvic organ
prolapse using genome-wide association analysis. Obstet Gynecol.
118:1345–1353. 2011.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gong R and Xia Z: Collagen changes in
pelvic support tissues in women with pelvic organ prolapse. Eur J
Obstet Gynecol Reprod Biol. 234:185–189. 2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Jameson SA, Swaminathan G, Dahal S, Couri
B, Kuang M, Rietsch A, Butler RS, Ramamurthi A and Damaser MS:
Elastin homeostasis is altered with pelvic organ prolapse in
cultures of vaginal cells from a lysyl oxidase-like 1 knockout
mouse model. Physiol Rep. 8(e14436)2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Campeau L, Gorbachinsky I, Badlani GH and
Andersson KE: Pelvic floor disorders: Linking genetic risk factors
to biochemical changes. BJU Int. 108:1240–1247. 2011.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Whitcomb EL, Rortveit G, Brown JS,
Creasman JM, Thom DH, Van Den Eeden SK and Subak LL: Racial
differences in pelvic organ prolapse. Obstet Gynecol.
114:1271–1277. 2009.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ra HJ and Parks WC: Control of matrix
metalloproteinase catalytic activity. Matrix Biol. 26:587–596.
2007.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Vulić M, Strinić T, Buković D, Tomić S,
Zupić T, Pavić M, Turcić P and Mihaljević S: Expression of matrix
metalloproteinase-1 in uterosacral ligaments tissue of women with
genital prolapse. Coll Antropol. 34:1411–1414. 2010.PubMed/NCBI
|
|
68
|
Strinic T, Vulic M, Tomic S, Capkun V,
Stipic I and Alujevic I: Matrix metalloproteinases-1, -2 expression
in uterosacral ligaments from women with pelvic organ prolapse.
Maturitas. 64:132–135. 2009.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Dviri M, Leron E, Dreiher J, Mazor M and
Shaco-Levy R: Increased matrix metalloproteinases-1,-9 in the
uterosacral ligaments and vaginal tissue from women with pelvic
organ prolapse. Eur J Obstet Gynecol Reprod Biol. 156:113–117.
2011.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Wu JM, Visco AG, Grass EA, Craig DM,
Fulton RG, Haynes C, Weidner AC and Shah SH: Matrix
metalloproteinase-9 genetic polymorphisms and the risk for advanced
pelvic organ prolapse. Obstet Gynecol. 120:587–593. 2012.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Wang X, Li Y, Chen J, Guo X, Guan H and Li
C: Differential expression profiling of matrix metalloproteinases
and tissue inhibitors of metalloproteinases in females with or
without pelvic organ prolapse. Mol Med Rep. 10:2004–2008.
2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Hu Y, Wu R, Li H, Gu Y and Wei W:
Expression and significance of metalloproteinase and collagen in
vaginal wall tissues of patients with pelvic organ prolapse. Ann
Clin Lab Sci. 47:698–705. 2017.PubMed/NCBI
|
|
73
|
Zhu YP, Xie T, Guo T, Sun ZJ, Zhu L and
Lang JH: Evaluation of extracellular matrix protein expression and
apoptosis in the uterosacral ligaments of patients with or without
pelvic organ prolapse. Int Urogynecol J. 32:2273–2281.
2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Rosenbloom J, Castro SV and Jimenez SA:
Narrative review: fibrotic diseases: Cellular and molecular
mechanisms and novel therapies. Ann Intern Med. 152:159–166.
2010.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Sun B, Zhou L, Wen Y, Wang C, Baer TM,
Pera RR and Chen B: Proliferative behavior of vaginal fibroblasts
from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod
Biol. 183:1–4. 2014.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Qi XY, Hong L, Guo FQ, Fu Q, Chen L and Li
BS: Expression of transforming growth factor-beta 1 and connective
tissue growth factor in women with pelvic organ prolapse. Saudi Med
J. 32:474–478. 2011.PubMed/NCBI
|
|
77
|
Liu C, Wang Y, Li BS, Yang Q, Tang JM, Min
J, Hong SS, Guo WJ and Hong L: Role of transforming growth factor
β-1 in the pathogenesis of pelvic organ prolapse: A potential
therapeutic target. Int J Mol Med. 40:347–356. 2017.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Hu H, Jiang H, Ren H, Hu X, Wang X and Han
C: AGEs and chronic subclinical inflammation in diabetes: Disorders
of immune system. Diabetes Metab Res Rev. 31:127–137.
2015.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Ramasamy R, Yan SF and Schmidt AM:
Advanced glycation endproducts: From precursors to RAGE: Round and
round we go. Amino Acids. 42:1151–1161. 2012.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Chen Y, Huang J, Hu C and Hua K:
Relationship of advanced glycation end products and their receptor
to pelvic organ prolapse. Int J Clin Exp Pathol. 8:2288–2299.
2015.PubMed/NCBI
|
|
81
|
Vetuschi A, Pompili S, Gallone A,
D'Alfonso A, Carbone MG, Carta G, Festuccia C, Gaudio E, Colapietro
A and Sferra R: Immunolocalization of advanced glycation end
products, mitogen activated protein kinases, and transforming
growth Factor-β/Smads in pelvic organ prolapse. J Histochem
Cytochem. 66:673–686. 2018.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Li L, Sima Y, Wang Y, Zhou J, Wang L and
Chen Y: The cytotoxicity of advanced glycation end products was
attenuated by UCMSCs in human vaginal wall fibroblasts by
inhibition of an inflammatory response and activation of
PI3K/AKT/PTEN. Biosci Trends. 14:263–270. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Chen YS, Wang XJ, Feng W and Hua KQ:
Advanced glycation end products decrease collagen I levels in
fibroblasts from the vaginal wall of patients with POP via the
RAGE, MAPK and NF-κB pathways. Int J Mol Med. 40:987–998.
2017.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Sima Y, Li L, Xiao C, Xu L, Wang L and
Chen Y: Advanced glycation end products (AGEs) downregulate the
miR-4429/PTEN axis to promote apoptosis of fibroblasts in pelvic
organ prolapse. Ann Transl Med. 10(821)2022.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Sima Y, Li J, Xu L, Xiao C, Li L, Wang L
and Chen Y: Quercetin antagonized advanced glycated end products
induced apoptosis and functional inhibition of fibroblasts from the
prolapsed uterosacral ligament. Drug Discov Ther. 17:415–427.
2024.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Li BS, Guo WJ, Hong L, Liu YD, Liu C, Hong
SS, Wu DB and Min J: Role of mechanical strain-activated PI3K/Akt
signaling pathway in pelvic organ prolapse. Mol Med Rep.
14:243–253. 2016.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Argraves WS, Greene LM, Cooley MA and
Gallagher WM: Fibulins: Physiological and disease perspectives.
EMBO Rep. 4:1127–1131. 2003.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Rahn DD, Acevedo JF, Roshanravan S, Keller
PW, Davis EC, Marmorstein LY and Word RA: Failure of pelvic organ
support in mice deficient in fibulin-3. Am J Pathol. 174:206–215.
2009.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Budatha M, Roshanravan S, Zheng Q,
Weislander C, Chapman SL, Davis EC, Starcher B, Word RA and
Yanagisawa H: Extracellular matrix proteases contribute to
progression of pelvic organ prolapse in mice and humans. J Clin
Invest. 121:2048–2059. 2011.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Budatha M, Silva S, Montoya TI, Suzuki A,
Shah-Simpson S, Wieslander CK, Yanagisawa M, Word RA and Yanagisawa
H: Dysregulation of protease and protease inhibitors in a mouse
model of human pelvic organ prolapse. PLoS One.
8(e56376)2013.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Khadzhieva MB, Kamoeva SV, Chumachenko AG,
Ivanova AV, Volodin IV, Vladimirov IS, Abilev SK and Salnikova LE:
Fibulin-5 (FBLN5) gene polymorphism is associated with pelvic organ
prolapse. Maturitas. 78:287–292. 2014.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Zhao BH and Zhou JH: Decreased expression
of elastin, fibulin-5 and lysyl oxidase-like 1 in the uterosacral
ligaments of postmenopausal women with pelvic organ prolapse. J
Obstet Gynaecol Res. 38:925–931. 2012.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Chin K, Wieslander C, Shi H, Balgobin S,
Montoya TI, Yanagisawa H and Word RA: Pelvic organ support in
animals with partial loss of fibulin-5 in the vaginal wall. PLoS
One. 11(e0152793)2016.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Liu X, Zhao Y, Gao J, Pawlyk B, Starcher
B, Spencer JA, Yanagisawa H, Zuo J and Li T: Elastic fiber
homeostasis requires lysyl oxidase-like 1 protein. Nat Genet.
36:178–182. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
95
|
Li Y, Nie N, Gong L, Bao F, An C, Cai H,
Yao X, Liu Y, Yang C, Wu B and Zou X: Structural, functional and
molecular pathogenesis of pelvic organ prolapse in patient and
Loxl1 deficient mice. Aging (Albany NY). 13:25886–25902.
2021.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Li Y, Wu B, An C, Jiang D, Gong L, Liu Y,
Liu Y, Li J, Ouyang H and Zou X: Mass cytometry and transcriptomic
profiling reveal body-wide pathology induced by Loxl1 deficiency.
Cell Prolif. 54(e13077)2021.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Kufaishi H, Alarab M, Drutz H, Lye S and
Shynlova O: Comparative characterization of vaginal cells derived
from premenopausal women with and without severe pelvic organ
prolapse. Reprod Sci. 23:931–943. 2016.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Connell KA, Guess MK, Chen HW, Lynch T,
Bercik R and Taylor HS: HOXA11 promotes fibroblast proliferation
and regulates p53 in uterosacral ligaments. Reprod Sci. 16:694–700.
2009.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Leppert PC: Tissue remodeling in the
female reproductive tract-a complex process becomes more complex:
The role of Hox genes. Biol Reprod. 86(98)2012.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Yılmaz N, Ozaksit G, Terzi YK, Yılmaz S,
Budak B, Aksakal O and Sahin FI: HOXA11 and MMP2 gene expression in
uterosacral ligaments of women with pelvic organ prolapse. J Turk
Ger Gynecol Assoc. 15:104–108. 2014.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Connell KA, Guess MK, Chen H, Andikyan V,
Bercik R and Taylor HS: HOXA11 is critical for development and
maintenance of uterosacral ligaments and deficient in pelvic
prolapse. J Clin Invest. 118:1050–1055. 2008.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Ma Y, Guess M, Datar A, Hennessey A,
Cardenas I, Johnson J and Connell KA: Knockdown of Hoxa11 in vivo
in the uterosacral ligament and uterus of mice results in altered
collagen and matrix metalloproteinase activity. Biol Reprod.
86(100)2012.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Zhang L, Dai F, Chen G, Wang Y, Liu S,
Zhang L, Xian S, Yuan M, Yang D, Zheng Y, et al: Molecular
mechanism of extracellular matrix disorder in pelvic organ
prolapses. Mol Med Rep. 22:4611–4618. 2020.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Yin Y, Qin M, Luan M and Xia Z: miR-19-3p
Promotes Autophagy and Apoptosis in Pelvic Organ Prolapse Through
the AKT/mTOR/p70S6K Pathway: Function of miR-19-3p on Vaginal
Fibroblasts by Targeting IGF-1. Female Pelvic Med Reconstr Surg.
27:e630–e638. 2021.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Jeon MJ, Kim EJ, Lee M, Kim H, Choi JR,
Chae HD, Moon YJ, Kim SK and Bai SW: MicroRNA-30d and microRNA-181a
regulate HOXA11 expression in the uterosacral ligaments and are
overexpressed in pelvic organ prolapse. J Cell Mol Med. 19:501–509.
2015.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Johanes I, Mihelc E, Sivasankar M and
Ivanisevic A: Morphological properties of collagen fibers in
porcine lamina propria. J Voice. 25:254–257. 2011.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Xie R, Xu Y, Fan S and Song Y:
Identification of differentially expressed genes in pelvic organ
prolapse by RNA-Seq. Med Sci Monit. 22:4218–4225. 2016.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Li J, Zhang J, Chu Z, Han H and Zhang Y:
FZD3 regulates the viability, apoptosis, and extracellular matrix
degradation of vaginal wall fibroblasts in pelvic organ prolapse
via the Wnt signaling pathway. J Biochem Mol Toxicol.
38(e23654)2024.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Nakad B, Fares F, Azzam N, Feiner B,
Zilberlicht A and Abramov Y: Estrogen receptor and laminin genetic
polymorphism among women with pelvic organ prolapse. Taiwan J
Obstet Gynecol. 56:750–754. 2017.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Xie T, Guo D, Guo T, Zhu Y, Li F, Zhang S,
Lang J and Sun Z: The protective effect of 17 β-estradiol on human
uterosacral ligament fibroblasts from postmenopausal women with
pelvic organ prolapse. Front Physiol. 13(980843)2022.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Ben-Zvi M, Herman HG, Schreiber L, Sagiv
R, Bar J, Condrea A and Ginath S: Expression of Heparanase in
uterosacral ligaments of women with or without uterine prolapse.
Eur J Obstet Gynecol Reprod Biol. 244:110–113. 2020.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Li C, Gong Y and Wang B: The efficacy of
pelvic floor muscle training for pelvic organ prolapse: A
systematic review and meta-analysis. Int Urogynecol J. 27:981–992.
2016.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Cox CK, Pandit A, Zawistowski M, Dutta D,
Narla G and Swenson CW: Genome-Wide association study of pelvic
organ prolapse using the michigan genomics initiative. Female
Pelvic Med Reconstr Surg. 27:502–506. 2021.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Halberthal-Cohen A, Burke YZ, Matanes E,
Amiel G and Lowenstein L: Modified colpocleisis for repair of
pelvic organ prolapse post-radical cystectomy. Int Urogynecol J.
31:409–410. 2020.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Lawson S and Sacks A: Pelvic floor
physical therapy and women's health promotion. J Midwifery Womens
Health. 63:410–417. 2018.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Lamvu G, Carrillo J, Witzeman K and
Alappattu M: Musculoskeletal considerations in female patients with
chronic pelvic pain. Semin Reprod Med. 36:107–115. 2018.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Barcz EM: Pelvic organ prolapse surgery.
What techniques should be used? Ginekol Pol. 94:771–772.
2023.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Dubinskaya ED, Gasparov AS, Babichevа IA
and Kolesnikova SN: Questions surrounding the optimal time for
surgical treatment of pelvic organ prolapse. Eur J Obstet Gynecol
Reprod Biol. 234:120–125. 2019.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Sarma S, Ying T and Moore KH: Long-term
vaginal ring pessary use: Discontinuation rates and adverse events.
BJOG. 116:1715–1721. 2009.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Mangir N, Aldemir Dikici B, Chapple CR and
MacNeil S: Landmarks in vaginal mesh development: polypropylene
mesh for treatment of SUI and POP. Nat Rev Urol. 16:675–689.
2019.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Blanchard V, Nyangoh-Timoh K, Fritel X,
Fauconnier A and Pizzoferrato AC: Importance of a pelvic floor
lifestyle program in women with pelvic floor dysfunctions: A pilot
study. J Gynecol Obstet Hum Reprod. 50(102032)2021.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Ryhtä I, Axelin A, Parisod H, Holopainen A
and Hamari L: Effectiveness of exercise interventions on urinary
incontinence and pelvic organ prolapse in pregnant and postpartum
women: Umbrella review and clinical guideline development. JBI Evid
Implement. 21:394–408. 2023.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Ho L, Macnab A, Matsubara Y, Peterson K,
Tsang B and Stothers L: Rating of pelvic floor muscle training
mobile applications for treatment of urinary incontinence in women.
Urology. 150:92–98. 2021.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Espiño-Albela A, Castaño-García C,
Díaz-Mohedo E and Ibáñez-Vera AJ: Effects of Pelvic-Floor Muscle
Training in Patients with Pelvic Organ Prolapse Approached with
Surgery vs. Conservative Treatment: A Systematic Review. J Pers
Med. 12(806)2022.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Due U, Brostrøm S and Lose G: Lifestyle
advice with or without pelvic floor muscle training for pelvic
organ prolapse: a randomized controlled trial. Int Urogynecol J.
27:555–563. 2016.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Basnet R: Impact of pelvic floor muscle
training in pelvic organ prolapse. Int Urogynecol J. 32:1351–1360.
2021.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Wang T, Wen Z and Li M: The effect of
pelvic floor muscle training for women with pelvic organ prolapse:
A meta-analysis. Int Urogynecol J. 33:1789–1801. 2022.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Lv A, Gai T, Zhang S, Feng Q and Li Y:
Electrical stimulation plus biofeedback improves urination
function, pelvic floor function, and distress after reconstructive
surgery: a randomized controlled trial. Int J Colorectal Dis.
38(226)2023.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Min L, Chunxue Y, Qiubo L, Xudong D, Yan
Z, Guifang Z, Kejia H, Tianzi G and Qing F: Effectiveness of
intravaginal electrical stimulation combined with electromyography
biofeedback-mediated pelvic floor muscle training for postpartum
symptomatic pelvic organ prolapse: Protocol for the PROSPECT
randomized trial. Trials. 23(131)2022.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Zhong F, Miao W, Yu Z, Hong L and Deng N:
Clinical effect of electrical stimulation biofeedback therapy
combined with pelvic floor functional exercise on postpartum pelvic
organ prolapse. Am J Transl Res. 13:6629–6637. 2021.PubMed/NCBI
|
|
131
|
Liu J, Yan W, Tang Y, Zhou Y, Yang S,
Xiang J, Zeng X, Xie F and Li X: Therapeutic effect of
proprioception training combined with pelvic floor electrical
stimulation biofeedback on postpartum pelvic floor dysfunction.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 47:1253–1259. 2022.PubMed/NCBI View Article : Google Scholar : (In Chinese,
English).
|
|
132
|
Vonthein R, Heimerl T, Schwandner T and
Ziegler A: Electrical stimulation and biofeedback for the treatment
of fecal incontinence: A systematic review. Int J Colorectal Dis.
28:1567–1577. 2013.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Hagen S, Stark D, Glazener C, Dickson S,
Barry S, Elders A, Frawley H, Galea MP, Logan J, McDonald A, et al:
Individualised pelvic floor muscle training in women with pelvic
organ prolapse (POPPY): A multicentre randomised controlled trial.
Lancet. 383:796–806. 2014.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Shah SM, Sultan AH and Thakar R: The
history and evolution of pessaries for pelvic organ prolapse. Int
Urogynecol J Pelvic Floor Dysfunct. 17:170–175. 2006.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Qiu J and Jiang D: Pessaries for managing
pelvic organ prolapse in women. Am Fam Physician. 103:660–661.
2021.PubMed/NCBI
|
|
136
|
Ramsay S, Tu le M and Tannenbaum C:
Natural history of pessary use in women aged 65-74 versus 75 years
and older with pelvic organ prolapse: A 12-year study. Int
Urogynecol J. 27:1201–1207. 2016.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Vardon D, Martin-Lasnel M, Agostini A,
Fauvet R and Pizzoferrato AC: Vaginal pessary for pelvic organ
prolapse: A survey among french gynecological surgeons. J Gynecol
Obstet Hum Reprod. 50(101833)2021.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Robert M, Govan AJ, Lohani U and Uprety A:
Feasibility of using pessaries for treatment of pelvic organ
prolapse in rural Nepal. Int J Gynaecol Obstet. 136:325–330.
2017.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Strohbehn K, Wadensweiler P and Hanissian
P: A novel, collapsible, space-occupying pessary for the treatment
of pelvic organ prolapse. Int Urogynecol J. 34:317–319.
2023.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Vaccaro CM, Mutema GK, Fellner AN, Crisp
CC, Estanol MV, Kleeman SD and Pauls RN: Histologic and cytologic
effects of vaginal estrogen in women with pelvic organ prolapse: A
randomized controlled trial. Female Pelvic Med Reconstr Surg.
19:34–39. 2013.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Ismail SI, Bain C and Hagen S: Oestrogens
for treatment or prevention of pelvic organ prolapse in
postmenopausal women. Cochrane Database Syst Rev.
2010(Cd007063)2010.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Cundiff GW, Weidner AC, Visco AG, Bump RC
and Addison WA: A survey of pessary use by members of the American
urogynecologic society. Obstet Gynecol. 95 (6 Pt 1):931–935.
2000.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Rapp DE, Congleton JY, Boatman K, Karp N
and Krupski T: Bilateral ureterovaginal fistulas and vesicovaginal
fistula in setting of retained pessary. Urology. 141:e11–e13.
2020.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Xie Y, Fan Y, Yang C, Wan R, Cheng X, Yang
X, Hu Y and Deng C: Efficacy and safety of Buzhong Yiqi decoction
combined with surgery for rectal prolapse: A protocol for
systematic review and meta analysis. Medicine (Baltimore).
99(e22732)2020.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Li J, Lin M and Zhu S: Efficacy and safety
of Shenqi Wenyang vaginal dilation suppository and biofeedback and
pelvic floor electrical stimulation in the treatment of stage
andⅡpelvic organ prolapse. Chin Prac Med. 18:20–24. 2023.(In
Chinese).
|
|
146
|
Wang M: Clinical study of Guyuan Shengti
Decoction combined with biofeedback electric stimulation in the
treatment of female mild and moderate pelvic organ prolapse
(unpublished PhD thesis). Nanjing University of Traditional Chinese
Medicine, 2022.
|
|
147
|
Van der Aa F and De Ridder D: Vaginal
pelvic organ prolapse repair using mesh: Let's welcome science into
the mesh debate. Eur Urol. 74:177–178. 2018.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Dong Y, Wang Y, Wang L and Sun L:
Laparoscopically monitored transvaginal extraperitoneal uterine
fixation with mesh for pelvic organ prolapse. Asian J Surg.
46:3109–3110. 2023.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Ellington DR and Richter HE: Indications,
contraindications, and complications of mesh in surgical treatment
of pelvic organ prolapse. Clin Obstet Gynecol. 56:276–288.
2013.PubMed/NCBI View Article : Google Scholar
|
|
150
|
Höfner K, Hampel C, Kirschner-Hermanns R,
Alloussi SH, Bauer RM, Bross S, Bschleipfer T, Goepel M, Haferkamp
A, Hüsch T, et al: Use of synthetic slings and mesh implants in the
treatment of female stress urinary incontinence and prolapse:
Statement of the Working Group on Urological Functional Diagnostics
and Female Urology of the Academy of the German Society of Urology.
Urologe A. 59:65–71. 2020.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
151
|
Debodinance P, Cosson M, Collinet P,
Boukerrou M, Lucot JP and Madi N: Synthetic meshes for transvaginal
surgical cure of genital prolapse: evaluation in 2005. J Gynecol
Obstet Biol Reprod (Paris). 35 (5 Pt 1):429–454. 2006.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
152
|
Barski D and Deng DY: Management of mesh
complications after SUI and POP Repair: Review and analysis of the
current literature. Biomed Res Int. 2015(831285)2015.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Mateu Arrom L, Errando Smet C, Gutierrez
Ruiz C, Araño P and Palou Redorta J: Pelvic organ prolapse repair
with mesh: Mid-Term efficacy and complications. Urol Int.
101:201–205. 2018.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Weintraub AY: Mesh Complications Following
POP Repair with or without Vaginal Hysterectomy. Isr Med Assoc J.
21:419–421. 2019.PubMed/NCBI
|
|
155
|
Ni J, Li H, Zhou Y, Gu B, Xu Y, Fu Q, Peng
X, Cao N, Fu Q, Jin M, et al: Therapeutic potential of human
adipose-derived stem cell exosomes in stress urinary
incontinence-an in vitro and in vivo study. Cell Physiol Biochem.
48:1710–1722. 2018.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Xu L, Sima Y, Xiao C and Chen Y: Exosomes
derived from mesenchymal stromal cells: A promising treatment for
pelvic floor dysfunction. Hum Cell. 36:937–949. 2023.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Hennes DMZB, Rosamilia A, Werkmeister JA,
Gargett CE and Mukherjee S: Endometrial SUSD2(+) mesenchymal
stem/stromal cells in tissue engineering: Advances in novel
cellular constructs for pelvic organ prolapse. J Pers Med.
11(840)2021.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Gargett CE, Gurung S, Darzi S, Werkmeister
JA and Mukherjee S: Tissue engineering approaches for treating
pelvic organ prolapse using a novel source of stem/stromal cells
and new materials. Curr Opin Urol. 29:450–457. 2019.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Wen J, Zhao Z, Fang F, Xiao J, Wang L,
Cheng J, Wu J and Miao Y: Prussian blue nanoparticle-entrapped
GelMA Gels Laden with mesenchymal stem cells as prospective
biomaterials for pelvic floor tissue repair. Int J Mol Sci.
24(2704)2023.PubMed/NCBI View Article : Google Scholar
|
